| SAR millions | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | Trend | YoY |
|---|---|---|---|---|---|---|---|
| Revenue | 190.8 | 241.8 | 240.3 | 226.6 | 201.9 | −10.9% | |
| Cost of revenue | 147.5 | 186.7 | 169.6 | 157.5 | 152.1 | −3.4% | |
| Gross profit | 43.2 | 55.1 | 70.7 | 68.2 | 49.8 | −26.9% | |
| Research & development | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Selling, general & administrative | 18.5 | 3.9 | 5.4 | 20.3 | 5.5 | −72.8% | |
| Selling & marketing | 7.5 | 1.1 | 1.7 | 8.5 | 0.7 | −92.0% | |
| Operating expenses | 18.5 | 17.4 | 25.2 | 17.8 | 23.3 | +30.5% | |
| Operating income | 24.7 | 37.7 | 45.5 | 50.3 | 26.5 | −47.3% | |
| Interest expense | 3.6 | 0.0 | 0.6 | 7.4 | 6.3 | −15.6% | |
| Interest income | 0.0 | 0.0 | 0.4 | 0.0 | 0.0 | — | |
| Other income / expense | (4.6) | (4.6) | (8.5) | (23.4) | (6.5) | +72.3% | |
| Pre-tax income | 20.1 | 33.1 | 37.0 | 27.0 | 20.1 | −25.6% | |
| Income tax | 0.8 | 1.1 | 1.2 | 0.5 | 1.3 | +148.4% | |
| Net income | 19.3 | 32.0 | 35.8 | 26.4 | 18.8 | −29.0% | |
| Discontinued operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Other net income adjustments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| EPS, basic (per share) | 1.38 | 2.29 | 2.56 | 1.89 | 1.34 | −29.1% | |
| EPS, diluted (per share) | 1.38 | 2.29 | 2.56 | 1.89 | 1.34 | −29.1% | |
| EBITDA | 38.8 | 53.4 | 53.6 | 51.3 | 44.1 | −14.1% | |
| Depreciation & amortization | 15.1 | 15.4 | 15.9 | 16.9 | 17.5 | +3.9% | |
| Weighted average shares (shares) | 14,000,000 | 14,000,000 | 14,000,000 | 14,000,000 | 13,999,000 | −0.0% | |
| Weighted average diluted shares (shares) | 14,000,000 | 14,000,000 | 14,000,000 | 14,000,000 | 13,999,000 | −0.0% | |
| Gross margin | 22.7% | 22.8% | 29.4% | 30.1% | 24.7% | −5.4 pts | |
| Operating margin | 13.0% | 15.6% | 18.9% | 22.2% | 13.1% | −9.1 pts | |
| Net margin | 10.1% | 13.3% | 14.9% | 11.7% | 9.3% | −2.4 pts |
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.
